🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Managements for refractory proficient mismatch repair (pMMR) or microsatell...
Status
Completed
Location
Hunan Cancer hospital
Start Date
2019-07-01
Trial ID
NCT05942768
Treatments Being Tested
This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Status
Recruiting
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2020-05-19
Trial ID
NCT05713994
The investigators propose to conduct a single-center, single-arm, Phase I c...
Status
Active Not Recruiting
Location
Colorectal Cancer, West China Hospital
Start Date
2025-02-21
Trial ID
NCT06865521
Treatments Being Tested
To determine if the regorafenib and nivolumab combination (RegoNivo) improv...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2021-05-05
Trial ID
NCT04879368
Treatments Being Tested
Colorectal cancer is one of the most common malignancies in China. Regorafe...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2019-03-12
Trial ID
NCT03946917
Treatments Being Tested
This study will evaluate the safety, tolerability, pharmacokinetic profile ...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2018-05-09
Trial ID
NCT03475251
Treatments Being Tested
The study is an interventional phase II clinical trial aiming to evaluate t...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2023-10-25
Trial ID
NCT06099821
Treatments Being Tested
The aim of this study is to the efficacy, prognosis, adverse effects, and f...
Status
Unknown
Location
The Second Affiliated Hospital of Fujian Medical University
Start Date
2022-01-20
Trial ID
NCT05717738
This is a multicenter, randomized, controlled, phase II study to evaluate t...
Status
Unknown
Location
Shanghai Zhongshan Hospital
Start Date
2022-07-13
Trial ID
NCT05278351
Treatments Being Tested
To evaluate the efficacy and safety of cadonilimab combined with Regorafeni...
Status
Recruiting
Location
Mengchao Hepatobiliary Hospital, Fujian Medical University
Start Date
2024-03-31
Trial ID
NCT06280105
Treatments Being Tested